Patni Rajiv

EVP, Chief R&D Officer at REATA PHARMACEUTICALS INC · on record since Jun 14, 2023
Director at IRulya Therapeutics Inc. · on record since Feb 15, 2024
Director at BioXcel Therapeutics, Inc. · on record since Jan 16, 2025
Chief Development Officer at Ocera Therapeutics, Inc. · on record since Sep 2, 2014
Chief Medical Officer at Adamas Pharmaceuticals Inc · on record since Jun 9, 2015
EVP, CMO at PORTOLA PHARMACEUTICALS INC · on record since Feb 11, 2020
Chief Medical Officer at Septerna, Inc. · on record since Sep 3, 2026

Insider trading activity of Patni Rajiv

Transactions on record: 28; since Sep 2, 2014

Open-market buys: 1; $20K

Open-market sells: 3; $64K

Companies traded: 7; last filing Sep 10, 2026

Figures computed from official regulatory filings — .

Companies where Patni Rajiv has traded

Septerna, Inc.1 tx · Sep 10, 2026
BioXcel Therapeutics, Inc.2 tx · Jan 12, 2026
IRulya Therapeutics Inc.3 tx · Jun 6, 2025
REATA PHARMACEUTICALS INC4 tx · Sep 26, 2023
PORTOLA PHARMACEUTICALS INC4 tx · $986.3K · Jul 2, 2020
Adamas Pharmaceuticals Inc10 tx · $166.4K · Apr 10, 2019
Ocera Therapeutics, Inc.4 tx · $20K · May 7, 2015

Track record of Patni Rajiv

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Patni Rajiv

Co-insiders of Patni Rajiv

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Septerna, Inc.Listing unverified	Sep 10, 2026	AwardD (derivative)	275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioXcel Therapeutics, Inc.Listing on record	Jan 12, 2026	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioXcel Therapeutics, Inc.Listing on record	Jan 16, 2025	AwardD (derivative)	44,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	13,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Feb 15, 2024	AwardD (derivative)	54,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Sep 26, 2023	Other	-45,000	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Sep 26, 2023	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Jun 14, 2023	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Jul 2, 2020	OtherD (derivative)	-35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Jul 2, 2020	OtherD (derivative)	-125,000	7.89 USD	$986.3K		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Mar 3, 2020	Award	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Mar 3, 2020	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Apr 10, 2019	Award	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Apr 10, 2019	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 21, 2019	Sell	-2,374	8.00 USD	$19K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 22, 2018	Sell	-1,252	25.94 USD	$32.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 9, 2018	AwardD (derivative)	54,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 9, 2018	Award	9,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 22, 2017	Sell	-733	17.04 USD	$12.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 8, 2016	Award	7,500	13.66 USD	$102.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 8, 2016	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Jun 9, 2015	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ocera Therapeutics, Inc.Listing unverified	May 7, 2015	Buy	5,050	3.97 USD	$20K	conv 89ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Septerna, Inc.Listing unverified	Sep 10, 2026	AwardD (derivative)	275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioXcel Therapeutics, Inc.Listing on record	Jan 12, 2026	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioXcel Therapeutics, Inc.Listing on record	Jan 16, 2025	AwardD (derivative)	44,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	13,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IRulya Therapeutics Inc.Listing on record	Feb 15, 2024	AwardD (derivative)	54,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Sep 26, 2023	Other	-45,000	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Sep 26, 2023	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Jun 14, 2023	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Jul 2, 2020	OtherD (derivative)	-35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Jul 2, 2020	OtherD (derivative)	-125,000	7.89 USD	$986.3K		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Mar 3, 2020	Award	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PORTOLA PHARMACEUTICALS INCListing unverified	Mar 3, 2020	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Apr 10, 2019	Award	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Apr 10, 2019	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 21, 2019	Sell	-2,374	8.00 USD	$19K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 22, 2018	Sell	-1,252	25.94 USD	$32.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 9, 2018	AwardD (derivative)	54,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 9, 2018	Award	9,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 22, 2017	Sell	-733	17.04 USD	$12.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 8, 2016	Award	7,500	13.66 USD	$102.5K		SEC
Adamas Pharmaceuticals IncListing unverified	Mar 8, 2016	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Jun 9, 2015	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ocera Therapeutics, Inc.Listing unverified	May 7, 2015	Buy	5,050	3.97 USD	$20K	conv 89ClusterFirst in 12mo	SEC